Amid the push to expand eligibility for the COVID-19 vaccine, the impact when it comes to children is unclear. The University of Oxford has launched a new study to assess the safety its vaccine in children, and says the trial will assess immune response in kids ages 6 to 17.
We discuss all issues related to children and the vaccine with Dr. Dean Fanelli.
,quality(10),blur(50))